The Estée Lauder Companies has announced a strategic minority investment in 111Skin, a London-based luxury skincare brand founded by plastic surgeon Dr. Yannis Alexandrides in 2012. Originally developed to accelerate post-surgical healing at his 111 Harley Street clinic, the label has become a global leader in “clinical-grade” beauty through its proprietary NAC Y2 repair complex and formulas priced up to $1,000. The partnership leverages 111Skin’s presence in North America and China and its prestige retail distribution, including Harrods.

Related reading: Functional luxury takes hold as China’s beauty market matures